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The interaction between the minor Fusariummycotoxins BEA and 13 bacterial strains characteristic of the
gastrointestinal tract as Biﬁdobacterium longum, Biﬁdobacterium biﬁdum, Biﬁdobacterium breve, Biﬁdo-
bacterium adolescentes, Lactobacillus rhamnosus, Lactobacillus casei-casei, Lactobacillus plantarum,
Eubacterium crispatus, Salmonella fecalis, Salmonella termoﬁlus, Lactobacillus ruminis, Lactobacillus casei
and Lactobacillus animalis was studied.
The fermentations were carried out in the liquid medium of MRS during 4, 12, 16, 24 and 48 h at 37 C,
under anaerobic conditions.
Levels of BEA in the fermentation liquid, on the cell walls and on the internal part of the cells were
determined using liquid chromatography coupled to the mass spectrometry detector (LC-MS/MS).
Results showed that the bacteria reduced the concentration of the BEA present in the medium, part of
the mycotoxin was adsorbed by cell wall and part internalized by the bacteria. All the bacteria analyzed
in this study showed a signiﬁcant BEA reduction during the fermentation process, in particular the mean
diminution resulted variable from 66 to the 83%.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
Beauvericin (BEA) is a cyclic hexadepsipeptide mycotoxinwhich
was originally isolated from Beauveria bassiana and later from
Paecilomyces fumosoroseus and Fusarium lateritium (Meca et al.,
2010). BEA has strong antibacterial, antifungal, and insecticidal
activities (Castlebury, Sutherland, Tanner, Henderson, & Cerniglia,
1999), and has also shown signiﬁcant cytotoxic activity toward
various human cancer cell lines. The notable antimicrobial and
cytotoxic activities of BEA have attracted research interest in its
application as a potential antibiotic and anticancer agent for human
health care (Jow, Chou, Chen, & Tsai, 2004; Zhang, Yan, Zhang,
Huang, & Chen, 2007).
BEA is most widely produced by many entomopathogenic
Fusarium fungal species (Fotso, Leslie, & Smith, 2002). In addition to
BEA, enniatins, which belong to another class of cyclicpeptides
having entomopathogenic activities, are also produced by many of
these Fusarium species. Nevertheless, BEA is the most common and
abundant mycotoxin, and plays a major role in the insecticidalþ34 96354954.
irgilio.it (G. Meca).
All rights reserved.activities of these Fusarium species (Moretti, Mule, Ritieni, &
Logrieco, 2007).
As regard the antibacterial activity of the BEA, Castlebury et al.
(1999) studied the action of this bioactive compound on bacteria
typically isolated from mammalian intestinal tract to understand
the interaction of the BEA with the normal intestinal microbiota
that has an important role in nutrition, physiology, and coloniza-
tion resistance to invasive pathogens. Also, Fotso and Smith (2003)
evaluated the BEA mutagenicity, utilizing the Ames test on Salmo-
nella typhimurium standard tester strain.
BEA has exhibited minimum inhibitory concentration (MIC)
values of 0.8e1.6 mg/mL against Mycobacterium tuberculosis, and
IC50 values of 1.3e2.4 mg/mL against Plasmodium falciparium
(Nilanota, Isaka, Kittakoop, & Trakulnaleamsai, 2002).
The potential toxic role of BEA is exempliﬁed by results from
in vitro studies using cell lines. For instance, BEA induces signiﬁcant
cell deaths in insect, murine, and human tumor cell lines (Calo
et al., 2003; Mazziotti & Perlmutter, 1998). Furthermore, BEA is
a potent and speciﬁc cholesterol acyltransferase inhibitor in rat
liver microsomes (Tomoda et al., 1992).
In mammalian cell lines, cell deaths caused by BEA have been
suggested to involve a Ca2þ dependent pathway, in which BEA
induces a signiﬁcant increase in intracellular Ca2þ concentration
G. Meca et al. / Food Control 28 (2012) 435e440436that leads death cell as a result of a combination of both apoptosis
and necrosis (Jow et al., 2004; Lin et al., 2005; Logrieco et al., 1998;
Nilanota et al., 2002; Ojcius, Zychlinsky, Zheng, & Young, 1991).
BEA is considered a normal contaminant of cereals and also of
products composed by cereals (Zinedine, Meca, Mañes, & Font,
2011). In particular, the presence of BEA in food commodities
has been recently reported during the last decade in some
European countries (Finland, Norway, Spain, Slovakia, Croatia,
Switzerland and Italy), in USA, in South Africa (Jestoi, 2008; Meca,
Zinedine, Blesa, Font, & Mañes, 2010; Munkvold, Stahr, Logrieco,
Moretti, & Ritieni, 1998; Ritieni et al., 1997; Shephard, Sewram,
Nieuwoudt, Marasas, & Ritieni, 1999; Zinedine et al., 2011) in
higher concentrations (milligrams per kilograms) respect to the
classical legislate Fusarium mycotoxins as the fumonisins or the
trichothecenes.
As regards the methodologies employed for the reduction of
this contaminant in food, in the scientiﬁc literature is present
only a US patent (Duvick & Rod, 1998) on the biological detoxi-
ﬁcation of the minor Fusarium mycotoxin BEA. In particular the
authors, employing as detoxiﬁcation agent a strain of Nocardia
Glubera, reduced the contamination by BEA in wheat kernels of
50% considering an initial contamination of the mycotoxin of
1000 mg/L.
The biological detoxiﬁcation strategies for the reduction of the
other Fusarium mycotoxins were studied by many authors. In
particular Young, Zhou, Yu, Zhu, and Gong (2007) evaluated the
degradation of 12 trichothecenes by chicken intestinal microbes
observing a complete conversion to the deepoxy metabolites of the
non-acylated trichothecenes and a deacetylation of the monoacetyl
trichothecenes.
Guan et al. (2009), evaluated the transformation of several
trichothecenes mycotoxins by microorganism isolated by ﬁsh
digesta, evidencing a completely transformation of the mycotoxin
deoxynivalenol (DON) to deepoxy DON (dE-DON) at 15 C in full
medium after 96 h incubation. The authors evidenced also that
most of the other trichotheceneswere transformed to deacetyl and/
or deepoxy products.
Islam, Zhou, Young, Goodwin, and Pauls (2011) studied the
aerobic and anaerobic deepoxydation of mycotoxin DON by
bacteria originating from agricultural soil. In particular the bacteria
isolated by the authors and related to the family of Serratia, Clos-
tridium, Citrobacter, Enterococcus, Stenotrophomonas, Streptomyces
produced through an enzyme process the de-epoxydized DON
after 60 h of incubation. Bacterial deepoxydation of DON occurred
also in the pH range 6.0e7.5, and a wide array of temperatures
(12e40 C).
Considering the lack of data on the biological detoxiﬁcation of
the minor Fusarium mycotoxins the aim of this study was to eval-
uate the reduction in vitro of the minor Fusarium mycotoxin BEA
employing different strains of probiotic bacteria as detoxiﬁcation
agents.
2. Material and methods
2.1. Chemicals
A stock standard solution of BEA (98% of purity) (SigmaeAldrich,
St. Luis, USA) was prepared by dissolving 1 mg of standard in 1 mL
of pure methanol, obtaining a 1 mg BEA/mL (1000 mg/mL) solution.
This stock solution was then diluted with methanol in order to
obtain the appropriated work solutions with concentrations of 1, 10
and 100 mg/L. All BEA solutions were stored in darkness at 4 C
until the LC-MS/MS analysis. Acetonitrile, methanol, water, ethyl
acetate (all of LC grade) and acetic acid were purchased fromMerck
(Whitehouse Station, NJ, USA).2.2. Strains and methodology
The study was carried out using 13 strains probiotic bacteria,
named Biﬁdobacterium longum, Biﬁdobacterium biﬁdum, Biﬁdo-
bacterium breve, Biﬁdobacterium adolescentes, Lactobacillus
rhamnosus, Lactobacillus casei-casei, Lactobacillus plantarum,
Eubacterium crispatus, Salmonella fecalis, Salmonella termoﬁlus,
Lactobacillus ruminis, Lactobacillus casei and Lactobacillus animalis.
The strains were obtained at the Spanish Type Culture Collection
(CECT Valencia, Spain), in sterile 18% glycerol.
For longer survival and higher quantitative retrieval of the
cultures, they were stored at 80 C. When needed, recovery of
strains was undertaken by two consecutive subcultures in appro-
priate media prior to use.
The microbes were cultured in 15 mL sterile plastic centrifuge
tubes utilizing as growth medium 10 mL of DeMan-Rogosa-
Sharpe (MRS broth, Oxoid Madrid, Spain) and incubated at
37 C in an anaerobic atmosphere with 95% CO2 and 5% H2 during
48 h. After that each bacterial suspensions at concentrations of
108 CFU/mL was added to a fresh 10 mL of MRS contaminated
with 5 mg/L of the mycotoxin BEA, incubated at 37 C in an
anaerobic atmosphere with 95% CO2 and 5% H2 during 4, 12, 16, 24
and 48 h.
The mediums were analyzed in order to determinate the
residual concentration of BEA present in the growth medium, the
toxin concentration adsorbed by bacteria on the cells wall, and also
the BEA amount internalized in the cells.
2.3. BEA extraction from fermented mediums
The fermentation tubes were centrifuged at 4000 rpm (Centri-
fuge 5810R, Eppendorf, Germany) during 5 min at 4 C in order to
separate the fermented medium from the cells. BEA contained in
fermented mediumwas extracted as follows (Jestoi, 2008). Five mL
of fermented MRS were introduced in a 20 mL plastic tube, and
extracted three times with 5mL of ethyl acetate using a vortex VWR
international (Barcelona, Spain) during 1 min. After that the
mixtures were centrifuged (Centrifuge 5810R, Eppendorf,
Germany) at 4000 rpm for 10 min at 4 C. The organic phases were
completely evaporated by a rotary evaporator (Buchi, Switzerland)
operating at 30 C and 30 mbar pressure, resuspended in 1 mL of
methanol, ﬁltered with 0.22 mM ﬁlters (Pheomenex, Madrid, Spain)
and analyzed by LC-MS/MS (Meca, Blaiotta, & Ritieni, 2010; Meca,
Zinedine, et al., 2010).
2.4. BEA extraction from cells wall
The BEA adsorbed on the cell walls was extracted suspending
the pellet, separated from the fermented medium, in 1 mL of saline
solution (0.90% NaCl, w/v) in a 1.5 mL vial. The extraction was
carried out by agitation with an orbital shaker (IKA Ks 260 basic,
Stanfen, Germany) for 12 h, then the samples were centrifuged at
4000 rpm (Centrifuge 5810R, Eppendorf, Germany) for 10 min at
4 C and the upper layer was ﬁltered with 0.22 mM ﬁlters (Pheo-
menex, Madrid, Spain) and analyzed by LC-MS/MS (Meca, Blaiotta,
et al., 2010; Meca, Zinedine, et al., 2010).
2.5. BEA extraction from cells
The BEA contained in the cells was determined as follows: cells
were sonicated in a saline solution (0.90% NaCl, w/v) for 30 min.
The pellet was suspended in 5 mL of saline solution, and 5 mL of
ethyl acetate was added. After mixing with a vortex for 1 min and
centrifuging (4000 rpm for 10 min at 4 C, Centrifuge 5810R,
Eppendorf, Germany), the upper layer, 5 mL approximately, were
Table 1
Beauvericin (BEA) contents (mg/L) in the fermentation medium MRS inoculated
with different strains of probiotic bacteria during fermentation.
Fermentation time
BEA mg/L
4 h 12 h 16 h 24 h 48 h Reduction
(%)
Bb. longum 3.6  0.2 3.0  0.2 2.2  0.3 1.8  0.1 1.3  0.1 74.0
Bb. biﬁdum 3.1  0.3 2.8  0.3 1.9  0.2 1.6  0.1 1.3  0.2 74.5
Bb. breve 3.3  0.3 2.7  0.2 2.0  0.1 1.7  0.2 1.3  0.1 74.5
Bb. adolescentis 3.3  0.3 3.2  0.3 1.8  0.3 1.4  0.1 1.2  0.1 76.2
Lb. rhamnosus 3.4  0.1 3.0  0.3 1.5  0.2 1.2  0.2 0.8  0.1 83.1
Lb. casei-casei 2.3  0.4 1.9  0.1 2.0  0.2 1.7  0.2 1.3  0.1 73.7
Lb. plantarum 3.5  0.2 3.0  0.3 2.0  0.1 1.9  0.2 1.2  0.1 76.5
E. crispatus 3.4  0.4 2.8  0.3 1.5  0.1 1.4  0.3 1.2  0.3 75.2
S. fecalis 3.3  0.4 3.1  0.4 2.9  0,3 1.5  0.1 1.7  0.4 66.5
S. termoﬁlus 3.7  0.5 3.2  0.3 1.6  0.2 1.5  0.2 1.3  0.2 73.4
Lb. ruminis 3.3  0.2 2.0  0.2 1.8  0.3 1.6  0.3 1.5  0.3 69.4
Lb. casei 3.2  0.1 3.0  0.3 1.7  0.3 1.7  0.2 1.1  0.2 77.7
Lb. animalis 3.7  0.3 3.1  0.2 1.5  0.2 1.3  0.2 1.1  0.1 78.0
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(Buchi, Switzerland), resuspended in 1 mL of methanol, ﬁltered
with 0.22 mM ﬁlters (Pheomenex, Madrid, Spain) and analyzed by
LC-MS/MS (Meca, Blaiotta, et al., 2010; Meca, Zinedine, et al.,
2010).
2.6. LC-MS/MS analysis of BEA
LC analysis of BEA was carried out with a TQ mass spectrometer
Quattro LC fromMicromass (Manchester, UK), equipped with an LC
Alliance 2690 system (Waters, Milford, MA) consisted of an auto-
sampler and a quaternary pump, a pneumatically assisted electro-
spray probe, a Z-spray interface. Mass Lynx NT software 4.1 was
used for data acquisition and processing. The autoinjector was
programmed to inject 20 mL into the Luna C18 column
(150  4.6 mm, 5 mm) Phenomenex maintained at 30 C. The
analytical separation for LC-MS/MS was performed using gradient
elution with water as mobile phase A, and acetonitrile as mobile
phase B, both containing 15 mM of ammonium formate. After an
isocratic step of 65% B for 3min, it was linearly increased to 75% B in
4 min and held constantly for 3 min. Flow rate was maintained at
0.3 mL min. Analysis was performed in positive ion modes. The ESI
source values were as follows: capillary voltage, 3.20 kV; source
temperature, 125 C; desolvation temperature, 350 C; desolvation
gas (nitrogen, 99.99% purity) ﬂow, 700 L/h. Identiﬁcation and
quantiﬁcation, in which protonated molecule [M þ H]þ of theTable 2
BEA adsorbed on the cell wall during the fermentation process.
Fermentation time
BEA mg/L
4 h 12 h 16 h
Bb. longum 46.5  2.4 57.3  2.2 76.2 
Bb. biﬁdum 120.0  3.2 125.3  3.2 162.3 
Bb. breve 64.2  2.6 101.2  3.3 182.2 
Bb. adolescentis 76.6  2.6 111.0  3.2 143.5 
Lb. rhamnosus 42.6  1.6 57.1  3.2 214.3 
Lb. casei-casei 65.7  3.2 102.0  2.4 126.3 
Lb. plantarum 51.0  2.5 55.1  2.6 127.1 
E. crispatus 56.8  2.2 96.2  2.7 141.2 
S. fecalis 25.7  2.3 48.0  1.5 52.8 
S. termoﬁlus 27.5  1.5 48.4  1.6 109.0 
Lb. ruminis 71.0  2.3 78.4  2.5 103.2 
Lb. casei 96.6  3.2 99.9  2.4 105.4 
Lb. animalis 43.0  2.5 45.4  2.1 53.9 analyte (BEA 784,34) was fragmented in the collision cell to the
product-ions (BEA 784,34-244,23).
The samples corresponding to the BEA present in the fermented
medium were also injected in the modality full scan with a m/z of
150e1500, to verify also the presence in the processed mediums of
somepossible adducts produced by the interaction of themycotoxin
BEAwith the cell wall of the probiotic bacteria (Meca et al., 2010).
3. Results and discussions
The potential reduction of the bioactive compound was moni-
tored during 4, 12, 16, 24 and 48 h. In the Table 1, are represented
the data related to the BEA present in the fermentation mediums
during the incubation time employed. In the ﬁrst 4 h incubation,
BEA decrease from 5 mg/L until a mean value of 3.31 mg/L. The
highest reduction value was evidenced by the strain of Lb. casei-
casei with a residual concentration of the bioactive compound in
the fermentation medium of 2.3  0.4 mg/L. At 12 h incubation the
mean BEA quantity decrease from 5 mg/L until 2.8 mg/L. In the
fermentation mediums fermented by Lb. casei-casei and Lb. ruminis
the residual BEA concentration was of 1.9  0.1 and 2.0  0.2 mg/L
respectively, evidencing at only 12 h incubation more than 50% of
degradation of the mycotoxin studied. From 16 to 24 h BEA
decreased meanly in the fermentation mediums from 1.8 to 1.5 mg/
L. In these incubation hours was possible to evidence a good
degradation activity by the strains of Lb. rhamnosus, Eubacterium
crispatus and Lb. animalis that evidenced at 24 h incubation,
residual BEA concentrations of 1.2  0.2, 1.4  0.3 and 1.3  0.2 mg/
L respectively. At 48 h incubation the probiotic bacteria employed
produced a mean BEA percent reduction of 74.8%, considering the
5 mg/L introduced as initial concentration. The bacterium that
reduced mainly the compound studied was the strain of Lb.
rhamnosus, with 83.1% of reduction. Good reduction values were
also evidenced by the strains of Lb. plantarum, Lb. casei and Lb.
animalis with 76.5, 77.7 and 78.0% respectively. As possible to
evidence in the Table 2, was also determined the percent of the BEA
adsorbed on the cell wall by the probiotic bacteria employed in this
study. In particular, the concentrations adsorbed are in the order of
micrograms per liters, very low concentrations considering the
5 mg/L introduced of the initial concentration. In particular as
remarked in the Table 2, at 48 h incubation, the mean adsorption
value was of 4.2% considering all the strains employed. The highest
absorption properties were evidenced by the strains of Lb. rham-
nosus and Lb. animaliswith 8.8 and 7.7% respectively. Summarizing,
very few quantities of the bioactive compound studied were
adsorbed by the bacteria employed.24 h 48 h Absorption (%)
2.3 97.3  2.2 127.2  2.2 2.5
3.5 161.2  2.3 198.3  2.6 4.0
3.3 205.4  3.3 229.5  3.1 4.6
3.4 163.5  3.6 176.7  1.8 3.5
3.6 396.4  4.2 434.5  3.5 8.7
4.2 139.2  3.6 180.4  1.6 3.6
2.4 170.2  1.6 198.4  2.3 4.0
2.6 172.4  2.4 201.4  2.2 4.0
1.6 92.6  1.2 123.6  1.6 2.5
2.2 136.5  1.5 146.8  1.5 2.9
2.3 167.2  1.4 187.7  1.5 3.7
2.6 144.2  1.2 169.4  1.8 3.4
1.6 361.4  2.8 387.2  3.2 7.7
Table 3
BEA internalized in the cells during the fermentation process.
Fermentation time
BEA mg/Kg
4 h 12 h 24 h 16 h 48 h Internalized (%)
Bb. longum 1.1  0.1 1.2  0.1 1.3  0.2 1.7  0.2 3.8  0.3 76.0
Bb. biﬁdum 0.9  0.09 1.8  0.3 2.1  0.2 2.2  0.3 4.0  0.5 79.8
Bb. breve 1.6  0.07 1.7  0.1 2.4  0.3 2.7  0.1 3.7  0.6 74.3
Bb. adolescentis 1.0  0.08 1.1  0.1 2.0  0.3 2.3  0.2 3.8  0.4 75.2
Lb. rhamnosus 0.6  0.07 1.2  0.2 1.9  0.2 3.0  0.3 3.9  0.3 77.8
Lb. casei-casei 0.9  0.08 1.5  0.2 1.9  0.4 2.7  0.4 3.8  0.5 75.6
Lb. plantarum 1.0  0.1 2.1  0.3 2.2  0.1 2.6  0.3 3.9  0.5 77.6
E. crispatus 0.6  0.07 0.6  0.08 1.8  0.3 2.1  0.1 2.2  0.2 44.0
S. fecalis 0.5  0.05 0.6  0.07 1.7  0.3 2.0  0.3 2.1  0.3 42.0
S. termoﬁlus 0.7  0.07 1.3  0.3 1.6  0.2 1.8  0.2 1.0  0.1 68.3
Lb. ruminis 1.0  0.1 1.1  0.07 1.4  0.1 1.9  0.3 3.2  0.3 64.4
Lb. casei 0.9  0.1 1.1  0.1 1.3  0.3 1.6  0.1 3.6  0.5 72.5
Lb. animalis 1.2  0.2 1.3  0.2 1.3  0.2 1.9  0.3 2.5  0.3 50.8
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bacteria employed can be absorbed by the strains tested, also the
BEA internalized by the cells was analyzed (Table 3). BEA
concentrations internalized by the cells increase during the
fermentation times and in particular from the mean value of
0.9 mg/kg evidenced in the ﬁrst 4 h, until to a mean value of
3.3 mg/kg at 48 h incubation. Evaluating the absorption data at
48 h incubation, the mean BEA percentage internalized by the cells
employed was of 67.5%. As is possible to show in the Table 3, the
majority part of the bioactive compound employed in this studyTIC of +Q1: from Sample 408 (10m4) of Peppe.wiff (Turbo Spray)
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Fig. 1. LC-MS scan chromatogram of the BEwas absorbed by the cells, reducing its concentration from the
fermentation medium.
To identify some possible adduct between the BEA and some
cells metabolites, the extracts corresponding to the BEA present in
the fermented mediums were injected in the LC-MS in the full scan
mode with a m/z a range variable from 150 to 1500 Da.
As is possible to observe in the Fig.1, near BEA peak is possible to
visualize another peak, not present in the control test, (medium
BEA free and fermented at the same incubation times), with a mass
spectra is evidenced in the Fig. 2.Max. 2.9e8 cps.
8 9 10 11 12 13 14
e, min
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10.15
13.69
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11.288.27
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BEA
BEA adduct 
A present in the fermented mediums.
 +Q1: 10.053 to 10.237 min from Sample 408 (10m4) of Peppe.wiff (Turbo Spray)
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((784.3+Na+)+Citocoline))+
Fig. 2. Mass spectra fragments (m/z 200e1500) of the BEA adduct. It’s possible to evidence in the mass spectra the presence of some fragments with a molecular weight highest
than the BEA, and probably related with an adducts with the minor Fusarium mycotoxin BEA and some phospholipids of the bacterial cell walls.
Table 4
BEA adduct expressed in mg/L of BEA present in the fermented medium during the
reduction process.
Fermentation time
BEA mg/L
4 h 12 h 16 h 24 h 48 h
Bb. longum 0.5  0.01 0.3  0.02 0.3  0.04 0.2  0.04 nd
Bb. biﬁdum 0.6  0.02 0.5  0.01 0.4  0.02 0.3  0.02 nd
Bb. breve 0.7  0.01 0.6  0.02 0.5  0.01 0.3  0.01 nd
Bb. adolescentis 0.7  0.02 0.6  0.03 0.5  0.03 0.3  0.01 nd
Lb. rhamnosus 0.5  0.03 0.5  0.02 0.4  0.03 0.3  0.02 nd
Lb. casei-casei 0.7  0.01 0.4  0.03 0.3  0.01 0.3  0.02 nd
Lb. plantarum 0.6  0.01 0.5  0.03 0.4  0.04 0.2  0.02 nd
E. crispatus 0.6  0.02 0.5  0.02 0.3  0.01 0.2  0.04 nd
S. fecalis 0.8  0.03 0.8  0.03 0.5  0.02 0.4  0.02 nd
S. termoﬁlus 0.6  0.01 0.4  0.02 0.3  0.03 0.2  0.01 nd
Lb. ruminis 0.6  0.02 0.4  0.02 0.3  0.02 0.2  0.03 nd
Lb. casei 0.6  0.01 0.5  0.02 0.3  0.03 0.2  0.01 nd
Lb. animalis 0.8  0.03 0.7  0.01 0.6  0.04 0.4  0.02 nd
G. Meca et al. / Food Control 28 (2012) 435e440 439In the mass spectra is possible to evidence a fragment corre-
sponding to the molecular weight of the BEA (m/z 784.3) and the
classical sodium adduct of BEA corresponding to the signal with
a m/z of 806.7 (783.3 þ Na)þ. These two fragments evidenced the
presence in this adduct of a BEA part. In the right part of the mass
spectra is possible to visualize two important diagnostic signals
with am/z of 1274.0 and 1295.8 respectively. The pseudomolecular
ion with m/z of 1274.0 represents an adduct of the (783.3 þ Na)þ
with the phosphatidilcoline, whereas the fragment withm/z 1295.8
represents an adduct (783.3 þ Na)þ with the citocoline, an inter-
mediate of the synthesis of the phosphatidilcoline. The identiﬁca-
tion of these two adducts was veriﬁed calculating the molecular
weight of the two compounds and relating these datawith the BEA.
The presence of these two fragments in the mass spectra demon-
strated that the BEA can interact with some component of the
bacterial cell wall, as the phospholipids, probably losing its toxicity.
The neoformed compound evidenced in the chromatogram has
been quantiﬁed during the fermentation process, and the data are
evidenced in the Table 4.
This study can be considered the ﬁrst work, where the degra-
dation of the minor Fusariummycotoxins BEA by probiotic bacteria
was evaluated, whereas the microbial degradation of other Fusa-
rium mycotoxins was studied by several authors.
The degradation of 12 trichothecenes mycotoxins by chicken
intestinal microbes was monitored by Young et al. (2007) applying
the liquid chromatographyeultraviolet-mass spectrometry detec-
tion under positive ion mode. The fermentations were operated bythe authors in themediumgrowth of L10, during 96 h at 37 C under
aerobic conditions. The two principally degradation pathways evi-
denced were: deacylation and deepoxydation. The authors evi-
denced also that the deepoxydation was the prevalent reaction in
HT-2 toxin and T-2 triol, whereas T2 toxin showed only deacetyla-
tion. The percent of reduction considering as start concentration for
each toxin employed the concentration of 50mg/L, resulted variable
from 40 to 95 %.
G. Meca et al. / Food Control 28 (2012) 435e440440Guan et al. (2009), evaluated the degradation of the Fusarium
mycotoxin DON, employing microorganisms of ﬁsh gut capable to
transform the trichothecenes in a less toxic compounds. The
detection of the DON and of the degradation products was carried
out by the authors employing the technique of the LC-MS. The
fermentation were carried out in different mediums as full
medium, nutrient broth and corn meal broth to study also how the
nutrients present in the mediums can inﬂuence the degradation of
the mycotoxins employed. The fermentations were operated in
a range of temperature variable from 4 to 25 C in aerobic condi-
tions. The authors evidenced that the microbial community from
one catﬁsh Ameiurus nebulosus, namely microbial culture C133,
completely transformed DON to deepoxy DON (dE-DON) at 15 C in
full medium after 96 h incubation.
Awad, Ghareeb, Bohm, and Zentek (2010), explained the detox-
iﬁcation properties of an Eubacterium strain (BBSH 797) isolated
frombovine rumen ﬂuid, to transformate completely themycotoxin
DON into 3a,7a,l5-trihydroxytrichothec-9, 12-dien-8-one (-de-
epoxy DON), which has been named DOM-1 in vitro and in vivo.
Bacterial mixtures originating from the rumen of dairy cow
showed both deacetylation and deepoxydation functions (Awad
et al., 2010).
Microbial transformations were obtained after the tested
mycotoxin was incubated in bacterial suspensions at 4.9  107 per
mL anaerobically at 38 C for 24 or 48 h.
Very effective deepoxydation activity was achieved when DON
was mixed with the digesta of the large intestines of chickens; DON
was completely transformed to DOM-1 (He, Young, & Forsberg,
1992). It was shown that the deepoxydation function of the intes-
tinal microorganisms of chickens may vary greatly among the
samples collected from different chicken varieties, individuals and
intestinal regions. The variation was also noticed in DON deep-
oxydation activity by microorganisms from swine intestine, either
no activity or with activity (Kollarczik, Gareis, & Hanelt, 1994).
Islam et al. (2011), employed different soil samples to realize
a screening of the micrograms capable to transform DON to dE-
DON. Microbial transformation was monitored employing of the
liquid chromatography coupled to the ultravioletemass spec-
trometry detection. The authors evidenced that a microbial culture
originated by a soil sample showed the 100% DON to dE-DON
biotransformation in mineral salt broth (MSB), after 144 h incu-
bation at the temperature of 25 C. Gene sequence analysis of the
bacteria in the enriched culture indicated the presence of at least
six bacterial genera, namely Serratia, Clostridium, Citrobacter,
Enterococcus, Stenotrophomonas and Streptomyces.Acknowledgments
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